'A Guide to Company Valuation for Life Sciences'
Thursday 14 January, 10:00 - 11:00
‘Guide to Company Valuation for Life Sciences’
Thursday 14 January, 10:00-11:00
A company is ultimately only worth what someone is willing to pay, and as the leader of a pre-revenue business, it is important to go into any discussion with investors fully prepared and armed with the right information. This will ensure you receive a fair valuation that addresses the future prospects of the firm and that the ratio of capital gained verses equity surrendered is appropriate.
During this digital session our industry experts will consider all the factors that contribute to the valuation process, and highlight all you need to know including:
- The importance of a future facing approach
- Ensuring you present a credible company story with numbers anchored in
- Have a clear history of the funding you’ve received to date and an indication of the equity and other benefits you’ve offered
- Be aware of valuation trends in the industry, particularly of similar companies
John Harris, CEO, OBN
Shawn Manning, Managing Director, Akesios Associates
Hitesh Thakrar, Partner, Syncona
About the event:
This session will be run in a live format using Zoom Webinar, with registration open for both OBN Members and Non-Members.
A live Q&A will follow the keynote presentations and audience members will be encouraged to engage with speakers by sending their questions in during the event.
OBN Members - Complimentary
Non-Members - £25+VAT
For all event enquiries, please contact: firstname.lastname@example.org.